Skip to Main ContentSkip to Footer

Michael R. Savona MD

Chief, Section of Hematology, Cellular Therapy and Stem Cell Transplantation, Beverly and George Rawlings Directorship of Hematology Research, and Professor of Medicine and Cancer Biology

Areas of Expertise

  • Cancer
  • Hematology
  • Hematology/Oncology
  • Leukemia, Acute and Chronic

Location

1301 Medical Center Drive, Suite 3903
Nashville, TN 37232

Languages

  • English
  • Spanish

Education

  • Doctor of Medicine

Board Certifications

  • Hematology - American Board of Internal Medicine, 2008

Patient Comments

Patient Comments are gathered from the Press Ganey Patient Experience Survey and displayed in full. Patients are not identified in order to respect patient privacy.
Dr. Savona was very caring and also showed real concern for my condition. He explained things so well and also made me feel very comfortable.
June 18, 2025
quote icon
Savonna is an excellent dr. He has so much knowledge and expertise in the field of blood cancer. Great personality also!!
June 15, 2025
quote icon
Love Dr. Savona! I believe that he truly cares about my health. Although sometimes, he does talk over my head and I have to get him to explain. He always tries to explain where I can have a better understanding.
May 27, 2025
quote icon
Dr. Savona and Katherine Kennedy are exceptional providers. They are well informed, thoughtful, and patient. They take my concerns seriously and work to make sure I'm getting the best treatment possible.
March 31, 2025
quote icon
Dr Savona is THE BEST!Discussed possible new treatment
February 17, 2025
quote icon
Dr Savona is the best.
February 16, 2025
quote icon
One of Vanderbilts very best Doctors. Brilliant and caring Dr.
February 13, 2025
quote icon
Dr. Savona is very personal. He always makes me feel heard and is compassionate. Though I had problems with the scheduling and the Nurse he was apologetic.
February 10, 2025
quote icon
Dr Savona was very informative. He took the time to educate me regarding my condition and talk about options and best avenue forward.
February 3, 2025
quote icon